Key facts
- This page summarizes Pamela P. Palmer's Form 4 filing for TALPHERA, INC. (TLPH).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 27 Feb 2024, 21:06.
Pamela P. Palmer - 14 Feb 2024 Form 4 Insider Report for TALPHERA, INC. (TLPH)
- Reporting relationship
- Chief Medical Officer, Director
- Issuer ticker
- TLPH
- Reported as of
- 14 Feb 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 27 Feb 2024, 21:06:44 UTC
- Prior SEC filing
- 13 Feb 2024
- Next SEC filing
- 04 Mar 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/Martha Adler, Attorney-In-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Pamela P. Palmer filed Form 4 for TALPHERA, INC. (TLPH) on 27 Feb 2024.
Change
- Previous filing in this sequence was filed on 13 Feb 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TLPH
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +18,000
- Change %
- +51%
- Price
- $0.000000
- Shares after
- 53,344
- Date
- 14 Feb 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TLPH
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +108,000
- Change %
- Price
- $0.000000
- Shares after
- 108,000
- Date
- 14 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 108,000
- Exercise price
- $1.03
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The restricted stock units shall vest in three equal consecutive annual installments on February 14, 2025, February 14, 2026 and February 14, 2027.
Footnote F2
On February 14, 2024, the reporting person was granted an option to purchase 108,000 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods.